Under construction – not a live service
Sign in
Taking peopleNo phase

Safety and Performance Assessment of the SYMBOL Range of Medical Devices in Patients Underlying Total Hip Arthroplasty

Key facts

Who runs it
Dedienne Sante S.A.S.
Where
France9 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
747 people, planned
Started
21 Sept 2021
Expected to end
Sept 2034
Type of study
Observational
Treatments tested
  • Total hip arthroplasty (primary or revision)
Record updated
27 August 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Patient age > 18 years at implantation
  • Patient who will undergo, during the study's period of inclusion, a total hip arthroplasty (primary or revision) with at least one SYMBOL medical device (DEDIENNE Santé)
  • Patient informed of his/her participation and willing to participate in the study
  • Patient able to read, write and understand French

Who cannot take part

  • Patient deprived of freedom, under guardianship/curatorship or placed under judicial protection
  • Patient unable to follow study procedures
  • Patient who has already been included in the study for a total hip arthroplasty (primary or revision) with at least one SYMBOL medical device

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this post-market clinical follow up study is to assess the safety and effectiveness of the SYMBOL range of medical devices. The study will evaluate the outcome of Total Hip Arthroplasty using medical devices from SYMBOL range over a period of 10 years.

The group in the trial

  • SYMBOL medical devices

    Patients undergoing total hip arthroplasty with at least one medical device from the SYMBOL range

    Treatment: Total hip arthroplasty (primary or revision)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
27 August 2024